Photographer: Andrey Rudakov/Bloomberg

Drugmakers Ensnared in Brexit Seek Sway Over Medicine Cabinets

  • Separate drug approval processes is ‘doomsday scenario’
  • European Medicines Agency may lose local skills, London home

The U.K.’s vote to break from the European Union has implications extending all the way to Britons’ medicine cabinets. 

To continue reading this article you must be a Bloomberg Professional Service Subscriber.